Pentagon to restart anthrax vaccination program

Defense Department officials announced Monday they are restarting a modified anthrax vaccine immunization program now that the vaccine provider has passed Food and Drug Administration scrutiny.

Only service members, essential civilians and contractor personnel going to or serving in high-threat areas will receive the vaccine, said Dr. Bill Winkenwerder, assistant defense secretary for health affairs. This is because half the contractor's vaccine production will be stockpiled for civilian use.

"We recognize there is a domestic need for access to the vaccine," Winkenwerder said during a news conference at the Pentagon. "In collaboration with the Department of Health and Human Services and the Office of Homeland Security, we are reserving a portion of the anthrax vaccine for stockpiling ... to use in the event of a domestic emergency."

In 1998, Defense began a plan to vaccinate all military members against the deadly, potential biological weapon. The program was pared down several times in the intervening years as the sole provider of the vaccine shut down its factory for renovations and then had problems gaining FDA approval of its production process.

Vaccine shortages eventually caused Defense to vaccinate only limited numbers of service members serving in "designated special mission units."

The contractor, Bioport of Lansing, Mich., gained FDA approval of its renovated facility in January and is now ready to begin providing additional stocks of the vaccine to Defense.

Winkenwerder said the new policy is "more targeted" than the previous plan to vaccinate the total force. He said the numbers of service members and essential civilians vaccinated will jump, but he would not say how high. Nor would he say what areas of the world are considered "higher threat."

"We will identify those areas to the service members before they are deployed to those areas, but we don't intend to talk publicly about that as we describe the policy to the rest of the country, to the media," Winkenwerder said during an earlier interview with American Forces Press Service. "And the reason is, we don't intend to give our adversaries an indication of exactly who and when and where we've immunized people. We would like that to be a further deterrent to anybody who might think about using anthrax as a weapon."

The doctor said Defense medical officials hope to start vaccinating targeted service members 45 days before they deploy. The anthrax vaccine requires six shots over an 18-month period for maximum immunity, but a relatively high level of immunity is reached after the first three shots, he explained.

Winkenwerder and Vice Adm. Gordon Holder, director of logistics on the Joint Staff, said the vaccination program may return to total-force coverage if vaccine availability improves and if the biological threat changes.

Individuals who started the six-shot series under the previous guidelines will resume the series where they left off.

Others who started the shots previously but are not currently covered under the new program will receive the rest of their shots "later into 2002, possibly as late as 2003, and that's because the supply of the vaccine is limited," Winkenwerder said.

He insisted there is no danger in stopping and restarting the series of shots. "Protection lasts months to years at some level," he said.

Under the previous program, 525,000 service members have received a total of 2.1 million doses of the vaccine. Contrary to widespread media reports of service members refusing to be vaccinated, even at the cost of their careers, Winkenwerder said the true number is relatively small compared to the number of doses administered. Defense has no formal method of counting refusals, but service chiefs report 441 service members have refused to be vaccinated. He said there have been no deaths linked to the vaccine.

In the earlier interview, Winkenwerder dismissed widespread claims that the vaccine isn't safe or effective. He cited a study released March 6 by the Institute of Medicine that found the vaccine to be "effective protection against anthrax, including inhalation anthrax."

"The Institute of Medicine of the National Academy of Sciences-a very august, prominent body-has said in a very large, in a very important, comprehensive report that the vaccine is safe and effective," Winkenwerder said earlier. Several other studies by reputable independent agencies have released similar conclusions.

Even though it is scaled back, the vaccination program will remain mandatory for troops in areas covered by the policy. Winkenwerder said this is no different from any number of other vaccines and "medical interventions" that are mandatory for military people based on where they are serving.

Defense is working with HHS to develop a new anthrax vaccine that would require fewer shots and be made using a different, easier method, said William F. Raub, deputy director of public health preparedness at HHS. The two departments are also examining the current vaccine to see if its protocol can be changed.

"We fight and win as teams," he said. "If a team of people are in an environment deployed in a military situation, I think the commander as well as all the individuals want to know are we all protected."

The anthrax attacks on the U.S. East Coast last fall may have silenced some critics. "I think the attacks last fall brought home the point that this is a real threat and that it's possible to manufacture this kind of bioweapon, and it's not altogether difficult to disseminate it," Winkenwerder said. "This is something that's not just in people's imagination. It is real."

American Forces Press Service reporter Jim Garamone contributed to this report.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.